Summary:
«Sankara Eye Foundation and Singapore-based Leben Care are deploying a comprehensive retina risk assessment software-as-a-service platform in India. Netra.AI, the cloud-based artificial intelligence (AI) solution, is powered by Intel technology and uses deep learning to identify retinal conditions in a short span of time with the accuracy level of human doctors. Netra.AI can identify diabetic retinopathy (DR), reducing the screening burden on vitreoretinal surgeons.
“India has one of the largest diabetic populations in the world and diabetic retinopathy is the major cause for vision loss and blindness in persons of working age. With Netra.AI, Sankara Eye Foundation and Leben Care have leveraged the power of Intel Xeon Scalable processors and built-in Intel Deep Learning (DL) Boost to accurately detect DR and enable timely treatment to effectively combat avoidable vision impairment and blindness in diabetic patients,” said Prakash Mallya, VP & MD of Sales, Marketing and Communications Group, Intel India.»
Article written by FE Bureau
15|03|2021
Source:
Financial Express